HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tatsuo Watanabe Selected Research

capsiate

3/2012Activation of transient receptor potential A1 by a non-pungent capsaicin-like compound, capsiate.
8/2011Capsiate, a non-pungent capsaicin analog, reduces body fat without weight rebound like swimming exercise in mice.
12/2003Upregulation of uncoupling proteins by oral administration of capsiate, a nonpungent capsaicin analog.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tatsuo Watanabe Research Topics

Disease

9Inflammation (Inflammations)
08/2021 - 01/2004
9Rheumatoid Arthritis
08/2021 - 01/2016
7Fever (Fevers)
02/2020 - 01/2004
6Neoplasms (Cancer)
02/2020 - 02/2008
6Body Weight (Weight, Body)
08/2011 - 12/2003
5Contact Dermatitis (Eczema, Contact)
05/2020 - 02/2009
4Periodontitis
01/2009 - 06/2006
4Hypothermia
04/2008 - 01/2004
3Obesity
09/2019 - 12/2003
2Bradycardia
11/2019 - 06/2016
2Periodontal Diseases (Periodontal Disease)
05/2013 - 03/2004
1Polyps
12/2020
1Intellectual Disability (Idiocy)
09/2020
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2020
1Neuroblastoma
02/2020
1Brain Neoplasms (Brain Tumor)
02/2020
1Neutropenia
02/2020
1Febrile Neutropenia
02/2020
1Hematologic Neoplasms (Hematological Malignancy)
02/2020
1Acute Kidney Injury (Acute Renal Failure)
01/2020
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020
1Philadelphia Chromosome
01/2020
1Rheumatic Diseases (Rheumatism)
09/2019
1Abdominal Pain (Pain, Abdominal)
02/2019
1Hepatocellular Carcinoma (Hepatoma)
01/2019
1Necrosis
01/2018
1Ependymoma
01/2018
1Sarcoma (Soft Tissue Sarcoma)
01/2017
1Thyroid Neoplasms (Thyroid Cancer)
11/2015

Drug/Important Bio-Agent (IBA)

10LipopolysaccharidesIBA
10/2011 - 01/2004
5lenvatinibIBA
01/2019 - 02/2008
5CytokinesIBA
03/2011 - 01/2004
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 02/2008
4Angiotensin IIIBA
01/2013 - 01/2004
48-Hydroxy-2'-DeoxyguanosineIBA
10/2011 - 10/2007
3Fluorescein-5-isothiocyanate (FITC)IBA
05/2020 - 11/2012
3Fluorescein (Funduscein)FDA LinkGeneric
05/2020 - 02/2009
3isothiocyanic acidIBA
05/2020 - 02/2009
3Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 02/2019
3phthalic acid (phthalate)IBA
01/2015 - 11/2012
3EstersIBA
01/2015 - 11/2012
3capsiateIBA
03/2012 - 12/2003
3Capsaicin (Zostrix)FDA Link
03/2012 - 01/2011
3PyrogensIBA
10/2011 - 01/2004
3Peptide Hydrolases (Proteases)FDA Link
10/2011 - 10/2007
3Triglycerides (Triacylglycerol)IBA
10/2008 - 03/2004
2C-Reactive ProteinIBA
08/2021 - 02/2020
2baricitinibIBA
08/2021 - 12/2020
2Anti-Bacterial Agents (Antibiotics)IBA
02/2020 - 07/2006
2Abatacept (Orencia)FDA Link
11/2019 - 09/2019
2Bevacizumab (Avastin)FDA Link
01/2018 - 09/2008
2oleuropeinIBA
01/2017 - 10/2008
2AnkyrinsIBA
01/2017 - 11/2012
2salicylhydroxamic acid (SHAM)IBA
09/2014 - 01/2013
2Indicators and Reagents (Reagents)IBA
05/2013 - 03/2004
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2013 - 10/2007
2Dibutyl Phthalate (Butyl Phthalate)IBA
11/2012 - 02/2009
2gingerolIBA
03/2011 - 04/2008
2Dinoprostone (PGE2)FDA Link
03/2011 - 01/2004
2Natriuretic PeptidesIBA
05/2010 - 09/2006
2CholesterolIBA
10/2008 - 06/2006
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2008 - 02/2008
2Phosphotransferases (Kinase)IBA
09/2008 - 02/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2007 - 01/2004
2Atrial Natriuretic Factor (ANF)IBA
11/2006 - 09/2006
2Interleukin-1 (Interleukin 1)IBA
11/2006 - 01/2004
2InterleukinsIBA
09/2006 - 03/2004
2Peptides (Polypeptides)IBA
07/2006 - 01/2004
2Interleukin-1beta (Interleukin 1 beta)IBA
06/2006 - 03/2004
1Prostaglandins AIBA
08/2021
1Janus Kinase InhibitorsIBA
08/2021
1tocilizumab (atlizumab)FDA Link
08/2021
1MicroplasticsIBA
12/2020
1piperineIBA
05/2020
1PiperacillinFDA LinkGeneric
02/2020
1Dasatinib (BMS 354825)FDA Link
01/2020
1Superoxide DismutaseIBA
11/2019
1CosmeticsIBA
09/2019
1Pharmaceutical PreparationsIBA
09/2019
1ORALIT (ORS)IBA
02/2019
1TantalumIBA
02/2019
1Biological ProductsIBA
03/2018
1Etoposide (VP 16)FDA LinkGeneric
01/2017
1Carboplatin (JM8)FDA LinkGeneric
01/2017
1pazopanibFDA Link
01/2017
1IfosfamideFDA LinkGeneric
01/2017
1MuscimolIBA
06/2016
1AtropineFDA LinkGeneric
06/2016
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2016
1Hyaluronic Acid (Hyaluronan)IBA
01/2016
1Capsules (Microcapsules)IBA
11/2015
1Antineoplastic Agents (Antineoplastics)IBA
11/2015

Therapy/Procedure

3Toothbrushing
01/2009 - 09/2002
2Drug Therapy (Chemotherapy)
02/2020 - 01/2020
2Therapeutics
01/2017 - 01/2014
1Transplantation
09/2020
1Biological Therapy
04/2019
1Hip Replacement Arthroplasty (Total Hip Replacement)
02/2019
1Proton Therapy
01/2018
1Intravenous Administration
06/2016